Time Source Company Announcement
19 Feb 2024 11:29 AM Form 8 (DD) - Custodian Property Income Reit plc
19 Feb 2024 11:26 AM Form 38.5b - Irish Residential Properties REIT PLC
19 Feb 2024 11:22 AM Positive update on SFX-01 in vitro GBM studies
19 Feb 2024 11:19 AM Holding(s) in Company
19 Feb 2024 11:17 AM Dividend approval & buyback program implementation
19 Feb 2024 11:16 AM TR1: Notification of major holdings
19 Feb 2024 11:07 AM Transaction in Own Shares
19 Feb 2024 11:00 AM Share Buyback
19 Feb 2024 10:59 AM EBT Share Purchase
19 Feb 2024 10:40 AM EBT Share Purchase
19 Feb 2024 10:33 AM Director/PDMR Shareholding
19 Feb 2024 10:30 AM Events of Default
19 Feb 2024 10:11 AM Compliance with Market Abuse Regulation
19 Feb 2024 10:00 AM Notice of Issuer Maturity Par Call
19 Feb 2024 09:51 AM Director/PDMR Shareholding
19 Feb 2024 09:49 AM Portfolio Update
19 Feb 2024 09:40 AM 2023 Separate Financial Statements
19 Feb 2024 09:35 AM Block listing Interim Review
19 Feb 2024 09:34 AM 2023 Consolidated Financial Statements
19 Feb 2024 09:30 AM Announcement relating to Premium Income
19 Feb 2024 09:30 AM Transaction in Own Shares
19 Feb 2024 09:16 AM Directorate Change
19 Feb 2024 09:11 AM To announce the Company's information
19 Feb 2024 09:09 AM Commencement of On Market Share Buyback Programme
19 Feb 2024 09:02 AM Holding(s) in Company
19 Feb 2024 09:00 AM Notice of Results and Investor Presentation
19 Feb 2024 08:56 AM SAYE Options, PDMR Dealings and EBT Shareholding
19 Feb 2024 08:07 AM Board meeting and close period
19 Feb 2024 08:00 AM Readmission - Location Sciences Group Plc
19 Feb 2024 07:51 AM Response to Press Speculation
19 Feb 2024 07:47 AM Holding(s) in Company
19 Feb 2024 07:45 AM Further re dividend approval
19 Feb 2024 07:45 AM Placement and Broker Option
19 Feb 2024 07:43 AM Dividend approval & buyback program implementation
19 Feb 2024 07:30 AM Half-year Report for the 6 months to 31 Dec 2023
19 Feb 2024 07:21 AM Issue of Equity
19 Feb 2024 07:19 AM Change of Broker
19 Feb 2024 07:10 AM Tagrisso plus chemo approved in US for lung cancer
19 Feb 2024 07:10 AM Transaction in Own Shares
19 Feb 2024 07:10 AM Transaction in Own Shares
19 Feb 2024 07:05 AM FDA accepts Dato-DXd BLA for nonsquamous NSCLC
19 Feb 2024 07:01 AM Results of Updated Mineral Resource Estimates
19 Feb 2024 07:01 AM Doc re. (Prelim FY2023 Investor Presentation)
19 Feb 2024 07:00 AM Proposed acquisition of Ameriabank CJSC
19 Feb 2024 07:00 AM Notice of Results and Investor Presentation
19 Feb 2024 07:00 AM Non-executive Director Resignation
19 Feb 2024 07:00 AM Director/PDMR Shareholding
19 Feb 2024 07:00 AM Appointment of Joint Broker
19 Feb 2024 07:00 AM Directorate Change
19 Feb 2024 07:00 AM Notice of Full Year Results
UK 100